SCHEMBL29407675

SCHEMBL29407675

Cn1c(C2(O)CCN(C(=O)OC(C)(C)C)C2)cc2c(Cl)ncnc21

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.37
CYP11B2 P19099 1/20 0.37
PIK3CD O00329 6/20 0.36
SYK P43405 1/20 0.36
SCD5 Q86SK9 1/20 0.36
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
ACACB O00763 2/20 0.35
JAK2 O60674 2/20 0.34
JAK1 P23458 2/20 0.34
USP30 Q70CQ3 1/20 0.34
NAMPT P43490 1/20 0.34
KIT P10721 1/20 0.34
GPR119 Q8TDV5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22676898 1.00 POLB (0.37) POLBCYP11B2PIK3CDSYKSCD5
SCHEMBL29452539 0.81 NAMPT (0.33) POLBCYP11B2PIK3CDSYKSCD5
SCHEMBL22676756 0.80 JAK2 (0.36) POLBPIK3CDACACBJAK2
SCHEMBL29407741 0.80 JAK2 (0.36) POLBPIK3CDACACBJAK2
SCHEMBL22658710 0.78 POLB (0.36) POLBCYP11B2PIK3CDSCD5ACACB
SCHEMBL29407750 0.78 POLB (0.36) POLBCYP11B2PIK3CDSCD5ACACB
SCHEMBL23326447 0.75 MKNK1 (0.36) POLBPIK3CD
SCHEMBL29861463 0.75 MKNK1 (0.36) POLBPIK3CD
SCHEMBL21143945 0.74 CYP11B2 (0.43) POLBCYP11B2SYKSCD5PDE4A
SCHEMBL3985126 0.73 POLB (0.40) POLBNAMPTKITGPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119874707-A FGFR inhibitors and methods of use thereof 传达治疗有限公司 2025-04-25 CN disclosed
CN-114126620-B FGFR inhibitors and methods of use thereof 传达治疗有限公司 2024-12-31 CN disclosed
CN-114126620-A FGFR inhibitors and methods of use thereof 传达治疗有限公司 2022-03-01 CN disclosed